BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Miura K, Ohnishi H. Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(23): 7381-7391 [PMID: 24966608 DOI: 10.3748/wjg.v20.i23.7381]
URL: https://www.wjgnet.com/1948-5182/full/v20/i23/7381.htm
Number Citing Articles
1
Praveen Kumar Conjeevaram Selvakumar, Mohammad Nasser Kabbany, Naim Alkhouri. Nonalcoholic Fatty Liver Disease in Children: Not a Small MatterPediatric Drugs 2018; 20(4): 315 doi: 10.1007/s40272-018-0292-2
2
Sok-Ja Janket, Martha E. Nunn, Erdjan Salih, Alison E. Baird. Translational Oral Health Research2018; : 81 doi: 10.1007/978-3-319-78205-8_8
3
Laura López-Gómez, Alexandra Alcorta, Raquel Abalo. Probiotics and Probiotic-like Agents against Chemotherapy-Induced Intestinal Mucositis: A Narrative ReviewJournal of Personalized Medicine 2023; 13(10): 1487 doi: 10.3390/jpm13101487
4
Stavros Bashiardes, Hagit Shapiro, Shachar Rozin, Oren Shibolet, Eran Elinav. Non-alcoholic fatty liver and the gut microbiotaMolecular Metabolism 2016; 5(9): 782 doi: 10.1016/j.molmet.2016.06.003
5
Isabella Reccia, Jayant Kumar, Cherif Akladios, Francesco Virdis, Madhava Pai, Nagy Habib, Duncan Spalding. Non-alcoholic fatty liver disease: A sign of systemic diseaseMetabolism 2017; 72: 94 doi: 10.1016/j.metabol.2017.04.011
6
Salvatore Pezzino, Maria Sofia, Gloria Faletra, Chiara Mazzone, Giorgia Litrico, Gaetano La Greca, Saverio Latteri. Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut MicrobiomeBiology 2022; 11(11): 1622 doi: 10.3390/biology11111622
7
Muhammad Y. Khan, Albana B. Mihali, Muhammad S. Rawala, Aysha Aslam, Waqas J. Siddiqui. The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease – a systematic review and meta-analysisEuropean Journal of Gastroenterology & Hepatology 2019; 31(6): 703 doi: 10.1097/MEG.0000000000001371
8
A. V. Bogolyubova, E. E. Mishina, P. O. Bogomolov, M. V. Matsievich, K. Yu. Kokina, A. Yu. Mayorov, P. V. Belousov. EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTSMedical Immunology (Russia) 2019; 21(5): 945 doi: 10.15789/1563-0625-2019-5-945-952
9
Kylynda C. Bauer, Paula T. Littlejohn, Victoria Ayala, Anna Creus-Cuadros, B. Brett Finlay. Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition PerspectiveGastroenterology 2022; 162(7): 1858 doi: 10.1053/j.gastro.2022.01.058
10
David Porras, Esther Nistal, Susana Martínez-Flórez, Sandra Pisonero-Vaquero, José Luis Olcoz, Ramiro Jover, Javier González-Gallego, María Victoria García-Mediavilla, Sonia Sánchez-Campos. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activationFree Radical Biology and Medicine 2017; 102: 188 doi: 10.1016/j.freeradbiomed.2016.11.037
11
Kouichi Miura, Mitsuaki Ishioka, Katsunori Iijima. The Roles of the Gut Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver DiseaseJournal of Obesity & Metabolic Syndrome 2017; 26(2): 86 doi: 10.7570/jomes.2017.26.2.86
12
Ridda Manzoor, Weshah Ahmed, Nariman Afify, Mashal Memon, Maryam Yasin, Hamda Memon, Mohammad Rustom, Mohannad Al Akeel, Noora Alhajri. Trust Your Gut: The Association of Gut Microbiota and Liver DiseaseMicroorganisms 2022; 10(5): 1045 doi: 10.3390/microorganisms10051045
13
Breann E Abernathy, Tonya C Schoenfuss, Allison S Bailey, Daniel D Gallaher. Polylactose Exhibits Prebiotic Activity and Reduces Adiposity and Nonalcoholic Fatty Liver Disease in Rats Fed a High-Fat DietThe Journal of Nutrition 2021; 151(2): 352 doi: 10.1093/jn/nxaa376
14
Audrey Neyrinck, Bernard Taminiau, Hannah Walgrave, Georges Daube, Patrice Cani, Laure Bindels, Nathalie Delzenne. Spirulina Protects against Hepatic Inflammation in Aging: An Effect Related to the Modulation of the Gut Microbiota?Nutrients 2017; 9(6): 633 doi: 10.3390/nu9060633
15
Aslı Yiğit, Gülhan Samur. Mechanisms behind the Role of SIBO in Non-Alcoholic Fatty Liver Disease: An Interplay between Liver, Gut Microbiota and NutritionCurrent Nutrition & Food Science 2023; 19(2): 84 doi: 10.2174/1573401318666220520100202
16
Mitsuaki Ishioka, Kouichi Miura, Shinichiro Minami, Yoichiro Shimura, Hirohide Ohnishi. Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse ModelsDigestive Diseases and Sciences 2017; 62(2): 396 doi: 10.1007/s10620-016-4393-x
17
Jun-Ling Han, Hui-Ling Lin. Intestinal microbiota and type 2 diabetes: From mechanism insights to therapeutic perspectiveWorld Journal of Gastroenterology 2014; 20(47): 17737-17745 doi: 10.3748/wjg.v20.i47.17737
18
Ya. M. Vakhrushev, E. V. Suchkova, A. P. Lukashevich. Evaluation of the effectiveness of differentiated therapy of non-alcoholic fatty liver diseaseTerapevticheskii arkhiv 2020; 92(2): 29 doi: 10.26442/00403660.2020.02.000400
19
Joanna K. Hodges, Geoffrey Y. Sasaki, Richard S. Bruno. Anti-inflammatory activities of green tea catechins along the gut–liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studiesThe Journal of Nutritional Biochemistry 2020; 85: 108478 doi: 10.1016/j.jnutbio.2020.108478
20
Paula Andréa Malveira Cavalcante, Marcos Fernandes Gregnani, Jessica Salles Henrique, Fábio Henrique Ornellas, Ronaldo Carvalho Araújo. Aerobic but not Resistance Exercise Can Induce Inflammatory Pathways via Toll-Like 2 and 4: a Systematic ReviewSports Medicine - Open 2017; 3(1) doi: 10.1186/s40798-017-0111-2
21
Alia Dadabhai. Integrating Nutrition Into Practice2017; : 375 doi: 10.1201/9781315100913-17
22
Dan Feng, Hongmin Zhang, Xin Jiang, Jun Zou, Qingrong Li, Haiyan Mai, Dongfang Su, Wenhua Ling, Xiang Feng. Bisphenol A exposure induces gut microbiota dysbiosis and consequent activation of gut-liver axis leading to hepatic steatosis in CD-1 miceEnvironmental Pollution 2020; 265: 114880 doi: 10.1016/j.envpol.2020.114880
23
Xingyao Pei, Shusheng Tang, Haiyang Jiang, Wenjuan Zhang, Gang Xu, Zonghui Zuo, Zhenhui Ren, Chun Chen, Yao Shen, Cun Li, Daowen Li. Paeoniflorin recued hepatotoxicity under zinc oxide nanoparticles exposure via regulation on gut-liver axis and reversal of pyroptosisScience of The Total Environment 2023; 904: 166885 doi: 10.1016/j.scitotenv.2023.166885
24
Kangxiao Guo, Sisheng Xu, Zhaofeng Zeng. “Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver diseaseFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1050709
25
Diptadip Dattaroy, Ratanesh Kumar Seth, Suvarthi Das, Firas Alhasson, Varun Chandrashekaran, Gregory Michelotti, Daping Fan, Mitzi Nagarkatti, Prakash Nagarkatti, Anna Mae Diehl, Saurabh Chatterjee. Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2016; 310(7): G510 doi: 10.1152/ajpgi.00259.2015
26
Daphne van der Heide, Ralf Weiskirchen, Ruchi Bansal. Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver DiseasesFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02852
27
Mustafa Karabicici, Yagmur Azbazdar, Evin Iscan, Gunes Ozhan. Misregulation of Wnt Signaling Pathways at the Plasma Membrane in Brain and Metabolic DiseasesMembranes 2021; 11(11): 844 doi: 10.3390/membranes11110844
28
Manfredi Rizzo, Alessandro Colletti, Peter E. Penson, Niki Katsiki, Dimitri P. Mikhailidis, Peter P. Toth, Ioanna Gouni-Berthold, John Mancini, David Marais, Patrick Moriarty, Massimiliano Ruscica, Amirhossein Sahebkar, Dragos Vinereanu, Arrigo Francesco Giuseppe Cicero, Maciej Banach, Julio Acosta, Mutaz Al-Khnifsawi, Fahad Alnouri, Fahma Amar, Atanas G. Atanasov, Gani Bajraktari, Maciej Banach, Ioanna Gouni-Berthold, Sonu Bhaskar, Agata Bielecka-Dąbrowa, Bojko Bjelakovic, Eric Bruckert, Ibadete Bytyçi, Alberto Cafferata, Richard Ceska, Arrigo F.G. Cicero, Krzysztof Chlebus, Xavier Collet, Magdalena Daccord, Olivier Descamps, Dragan Djuric, Ronen Durst, Marat V. Ezhov, Zlatko Fras, Dan Gaita, Ioanna Gouni-Berthold, Adrian V. Hernandez, Steven R. Jones, Jacek Jozwiak, Nona Kakauridze, Amani Kallel, Niki Katsiki, Amit Khera, Karam Kostner, Raimondas Kubilius, Gustavs Latkovskis, G.B. John Mancini, A. David Marais, Seth S. Martin, Julio Acosta Martinez, Mohsen Mazidi, Dimitri P. Mikhailidis, Erkin Mirrakhimov, Andre R. Miserez, Olena Mitchenko, Natalya P. Mitkovskaya, Patrick M. Moriarty, Seyed Mohammad Nabavi, Devaki Nair, Demosthenes B. Panagiotakos, György Paragh, Daniel Pella, Peter E. Penson, Zaneta Petrulioniene, Matteo Pirro, Arman Postadzhiyan, Raman Puri, Ashraf Reda, Željko Reiner, Dina Radenkovic, Michał Rakowski, Jemaa Riadh, Dimitri Richter, Manfredi Rizzo, Massimiliano Ruscica, Amirhossein Sahebkar, Maria-Corina Serban, Abdullah M.A Shehab, Aleksandr B. Shek, Cesare R. Sirtori, Claudia Stefanutti, Tomasz Tomasik, Peter P. Toth, Margus Viigimaa, Pedro Valdivielso, Dragos Vinereanu, Branislav Vohnout, Stephan von Haehling, Michal Vrablik, Nathan D. Wong, Hung-I Yeh, Jiang Zhisheng, Andreas Zirlik. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)Pharmacological Research 2023; 189: 106679 doi: 10.1016/j.phrs.2023.106679
29
Marija Branković, Igor Jovanović, Marija Dukić, Tijana Radonjić, Svetlana Oprić, Slobodan Klašnja, Marija Zdravković. Lipotoxicity as the Leading Cause of Non-Alcoholic SteatohepatitisInternational Journal of Molecular Sciences 2022; 23(9): 5146 doi: 10.3390/ijms23095146
30
Alejandra Altamirano-Barrera, Misael Uribe, Norberto C. Chávez-Tapia, Natalia Nuño-Lámbarri. The role of the gut microbiota in the pathology and prevention of liver diseaseThe Journal of Nutritional Biochemistry 2018; 60: 1 doi: 10.1016/j.jnutbio.2018.03.006
31
Yujing Fan, Yunpeng Li, Yanjie Chu, Jing Liu, Lin Cui, Dekai Zhang. Toll-Like Receptors Recognize Intestinal Microbes in Liver CirrhosisFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.608498
32
Wei-Lin Wang, Shao-Yan Xu, Zhi-Gang Ren, Liang Tao, Jian-Wen Jiang, Shu-Sen Zheng. Application of metagenomics in the human gut microbiomeWorld Journal of Gastroenterology 2015; 21(3): 803-814 doi: 10.3748/wjg.v21.i3.803
33
Ebrahim Abbasi Oshaghi. Role of Toll-like Receptor 4 in the Development of Non-alcoholic Fatty Liver DiseaseAvicenna Journal of Medical Biochemistry 2018; 6(2): 24 doi: 10.15171/ajmb.2018.06
34
Rosa Lombardi, Giuseppina Pisano, Silvia Fargion, Anna Ludovica Fracanzani. Cardiovascular involvement after liver transplantation: role of non-alcoholic fatty liver disease and non-alcoholic steatohepatitisExploration of Medicine 2021;  doi: 10.37349/emed.2021.00030
35
Brandon Perumpail, Andrew Li, Nimy John, Sandy Sallam, Neha Shah, Waiyee Kwong, George Cholankeril, Donghee Kim, Aijaz Ahmed. The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLDDiseases 2019; 7(1): 27 doi: 10.3390/diseases7010027
36
Mingnuan Han, Ting Zhang, Wen Gu, Xingxin Yang, Ronghua Zhao, Jie Yu. 2,3,5,4'‑tetrahydroxy‑stilbene‑2‑O‑β‑D‑glucoside attenuates methionine and choline‑deficient diet‑induced non‑alcoholic fatty liver diseaseExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6300
37
Seyyed Mohammad Reza Hashemnia, Reza Meshkani, Fahimeh Zamani-Garmsiri, Maryam Shabani, Maryam Tajabadi-Ebrahimi, Iraj Ragerdi Kashani, Seyed Davar Siadat, Samaneh Mohassel Azadi, Solaleh Emamgholipour. Amelioration of obesity-induced white adipose tissue inflammation by Bacillus coagulans T4 in a high-fat diet-induced obese murine modelLife Sciences 2023; 314: 121286 doi: 10.1016/j.lfs.2022.121286
38
Libin Chen, Xintong Jin, Jian Ma, Bo Xiang, Xiayu Li. YAP at the progression of inflammationFrontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1204033
39
Yuan Gao, Tian Tian. mTOR Signaling Pathway and Gut Microbiota in Various Disorders: Mechanisms and Potential Drugs in PharmacotherapyInternational Journal of Molecular Sciences 2023; 24(14): 11811 doi: 10.3390/ijms241411811
40
Kelli A. Lytle, Carmen P. Wong, Donald B. Jump, Anna Alisi. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- micePLOS ONE 2017; 12(4): e0173376 doi: 10.1371/journal.pone.0173376
41
Wenyu Zhao, Min Guo, Jun Feng, Zhennan Gu, Jianxin Zhao, Hao Zhang, Gang Wang, Wei Chen. Myristica fragrans Extract Regulates Gut Microbes and Metabolites to Attenuate Hepatic Inflammation and Lipid Metabolism Disorders via the AhR–FAS and NF-κB Signaling Pathways in Mice with Non-Alcoholic Fatty Liver DiseaseNutrients 2022; 14(9): 1699 doi: 10.3390/nu14091699
42
Rongxue Wei, Chunchun Han, Shouhai Wei, Yongqiang Teng, Liang Li, Hehe Liu, Shengqiang Hu, Bo Kang, Hengyong Xu. Integrative analysis of transcriptome and lipidome reveals fructose pro-steatosis mechanism in goose fatty liverFrontiers in Nutrition 2023; 9 doi: 10.3389/fnut.2022.1052600
43
Benedetta Campana, David Semela, Markus Heim, Christine Bernsmeier. Non-Alcoholic Fatty Liver Disease – Changing the Prevalence of Liver Cancer?EMJ Hepatology 2015; : 12 doi: 10.33590/emjhepatol/10314903
44
Bharati Kadamb Patel, Kadamb Haribhai Patel, Shabbir M. Moochhala. Gut microbiota intervention strategies using active components from medicinal herbs to evaluate clinical efficacy of type 2 diabetes – A reviewClinical and Translational Discovery 2023; 3(1) doi: 10.1002/ctd2.170
45
Josip Stojic, Michał Kukla, Ivica Grgurevic. The Intestinal Microbiota in the Development of Chronic Liver Disease: Current StatusDiagnostics 2023; 13(18): 2960 doi: 10.3390/diagnostics13182960
46
Minghui Zhu, Omer M. A. Dagah, Billton Bryson Silaa, Jun Lu. Thioredoxin/Glutaredoxin Systems and Gut Microbiota in NAFLD: Interplay, Mechanism, and Therapeutical PotentialAntioxidants 2023; 12(9): 1680 doi: 10.3390/antiox12091680
47
Ting Bao, Fang He, Xiaoxia Zhang, Lili Zhu, Zhen Wang, Haixia Lu, Ting Wang, Yiwei Li, Shaoqi Yang, Hao Wang. Inulin Exerts Beneficial Effects on Non-Alcoholic Fatty Liver Disease via Modulating gut Microbiome and Suppressing the Lipopolysaccharide-Toll-Like Receptor 4-Mψ-Nuclear Factor-κB-Nod-Like Receptor Protein 3 Pathway via gut-Liver Axis in MiceFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.558525
48
Hailong Li, Ziyang Xie, Yao Zhang, Yue Liu, Aijing Niu, Yingying Liu, Linbo Zhang, Lili Guan. Rosa rugosa polysaccharide attenuates alcoholic liver disease in mice through the gut-liver axisFood Bioscience 2021; 44: 101385 doi: 10.1016/j.fbio.2021.101385
49
Alimire Abulikemu, Xinying Zhao, Hailin Xu, Yan Li, Ru Ma, Qing Yao, Ji Wang, Zhiwei Sun, Yanbo Li, Caixia Guo. Silica nanoparticles aggravated the metabolic associated fatty liver disease through disturbed amino acid and lipid metabolisms-mediated oxidative stressRedox Biology 2023; 59: 102569 doi: 10.1016/j.redox.2022.102569
50
Garima Maheshwari, Gaiping Wen, Denise K. Gessner, Robert Ringseis, Günter Lochnit, Klaus Eder, Holger Zorn, Thomas Timm. Tandem mass tag-based proteomics for studying the effects of a biotechnologically produced oyster mushroom against hepatic steatosis in obese Zucker ratsJournal of Proteomics 2021; 242: 104255 doi: 10.1016/j.jprot.2021.104255
51
Lu-Jie Liu, Yu-Rong Kang, Yan-Feng Xiao. Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesityWorld Journal of Pediatrics 2021; 17(4): 394 doi: 10.1007/s12519-021-00444-x
52
Jing Xiao, Huanyu Xiang, Hongyan Xiang, Zilin Sun, Jing Xu, Hong Ren, Peng Hu, Mingli Peng. GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARγ/CD36 pathway and altering the gut microbiotaEuropean Journal of Pharmacology 2023; 960: 176113 doi: 10.1016/j.ejphar.2023.176113
53
Jarren R. Oates, Melanie C. McKell, Maria E. Moreno-Fernandez, Michelle S. M. A. Damen, George S. Deepe, Joseph E. Qualls, Senad Divanovic. Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac AttackFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02893
54
Fan Xiong, Shangong Wu, Lu Qin, Mijuan Shi, Wenxiang Li, Hong Zou, Ming Li, Guitang Wang. Transcriptome analysis of grass carp provides insights into disease-related genes and novel regulation pattern of bile acid feedback in response to lithocholic acidAquaculture 2019; 500: 613 doi: 10.1016/j.aquaculture.2018.10.015
55
Daiyang Xia, Lin Yang, Yu Li, Jianying Chen, Xiufen Zhang, Heng Wang, Shuangshuang Zhai, Xianzhi Jiang, Giuseppe Meca, Shunxiang Wang, Liang Huang, Shanshan Zhu, Yang Fu, Weiqing Ma, Yongwen Zhu, Hui Ye, Wence Wang. Melatonin alleviates Ochratoxin A-induced liver inflammation involved intestinal microbiota homeostasis and microbiota-independent mannerJournal of Hazardous Materials 2021; 413: 125239 doi: 10.1016/j.jhazmat.2021.125239
56
Amedeo Lonardo, Fabio Nascimbeni, Mauro Maurantonio, Alessandra Marrazzo, Luca Rinaldi, Luigi Elio Adinolfi. Nonalcoholic fatty liver disease: Evolving paradigmsWorld Journal of Gastroenterology 2017; 23(36): 6571-6592 doi: 10.3748/wjg.v23.i36.6571
57
Lu Huang, Wei Ding, Ming-Qiang Wang, Zheng-Gen Wang, Hong-Hui Chen, Wen Chen, Qiong Yang, Ting-Na Lu, Qing Yang, Ji-Man He. Tanshinone IIA ameliorates non-alcoholic fatty liver disease through targeting peroxisome proliferator-activated receptor gamma and toll-like receptor 4Journal of International Medical Research 2019; 47(10): 5239 doi: 10.1177/0300060519859750
58
Satdarshan P.S. Monga, Jaideep Behari. Molecular Pathology2018; : 417 doi: 10.1016/B978-0-12-802761-5.00020-1
59
Cynthia Aparecida de Castro, Manoela Maciel dos Santos Dias, Karina Ana da Silva, Sandra Aparecida dos Reis, Lisiane Lopes da Conceição, Letícia De Nadai Marcon, Luis Fernando de Sousa Moraes, Maria do Carmo Gouveia Peluzio. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2015; : 1 doi: 10.1007/978-94-007-7742-2_1-1
60
Mengdi Guo, Chenhui Zhu, Rongzhan Fu, Xiaoxuan Ma, Zhiguang Duan, Daidi Fan. Ginsenoside Rk3 Regulates Nonalcoholic Steatohepatitis by Modulation of Intestinal Flora and the PI3K/AKT Signaling Pathway in C57BL/6 MiceJournal of Agricultural and Food Chemistry 2023; 71(24): 9370 doi: 10.1021/acs.jafc.3c00789
61
MIN WANG, SHUIPING ZHAO, MINGYUE TAN. bZIP transmembrane transcription factor CREBH: Potential role in non-alcoholic fatty liver disease (Review)Molecular Medicine Reports 2016; 13(2): 1455 doi: 10.3892/mmr.2015.4749
62
Gloria Komazin, Michael Maybin, Ronald W. Woodard, Thomas Scior, Dominik Schwudke, Ursula Schombel, Nicolas Gisch, Uwe Mamat, Timothy C. Meredith. Substrate structure-activity relationship reveals a limited lipopolysaccharide chemotype range for intestinal alkaline phosphataseJournal of Biological Chemistry 2019; 294(50): 19405 doi: 10.1074/jbc.RA119.010836
63
Ting‐Chin David Shen, Nikolaos Pyrsopoulos, Vinod K. Rustgi. Microbiota and the liverLiver Transplantation 2018; 24(4): 539 doi: 10.1002/lt.25008
64
Ting Wang, Taichi Ishikawa, Minoru Sasaki, Toshimi Chiba. Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Porphyromonas gingivalisFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.822190
65
Somaya Albhaisi, Arun J. Sanyal. Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic SteatohepatitisFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.665987
66
Ya. M. Vakhrushev, A. P. Lukashevich, E. V. Suchkova. Evaluation of enterohepatic circulation of the bile acids in patients with non-alcoholic fatty liver diseaseExperimental and Clinical Gastroenterology 2023; (8): 73 doi: 10.31146/1682-8658-ecg-216-8-73-78
67
Angelica Carreira dos Santos, Daniel Araki Ribeiro, Jessica Almeida da Cruz Ferreira, Odair Aguiar, Dan Linetzky Waitzberg, Claudia Cristina Alves. Inflammatory gene expression analysis after prebiotic, probiotic and synbiotic supplementation in experimental nonalcoholic fatty liver diseaseNutrition & Food Science 2019; 49(1): 75 doi: 10.1108/NFS-04-2018-0119
68
Dan Feng, Jun Zou, Dongfang Su, Haiyan Mai, Shanshan Zhang, Peiyang Li, Xiumei Zheng. Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE−/− mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammationNutrition & Metabolism 2019; 16(1) doi: 10.1186/s12986-019-0410-3
69
Graciela Arguello, Elisa Balboa, Marco Arrese, Silvana Zanlungo. Recent insights on the role of cholesterol in non-alcoholic fatty liver diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015; 1852(9): 1765 doi: 10.1016/j.bbadis.2015.05.015
70
Xiang Zhang, Olabisi Oluwabukola Coker, Eagle SH Chu, Kaili Fu, Harry C H Lau, Yi-Xiang Wang, Anthony W H Chan, Hong Wei, Xiaoyong Yang, Joseph J Y Sung, Jun Yu. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolitesGut 2021; 70(4): 761 doi: 10.1136/gutjnl-2019-319664
71
Wan-Ju Yeh, Jung Ko, Wen-Chih Huang, Wei-Yi Cheng, Hsin-Yi Yang. Crude extract of Camellia oleifera pomace ameliorates the progression of non-alcoholic fatty liver disease via decreasing fat accumulation, insulin resistance and inflammationBritish Journal of Nutrition 2020; 123(5): 508 doi: 10.1017/S0007114519003027
72
Jinliang Du, Rui Jia, Liping Cao, Zhengyan Gu, Qin He, Pao Xu, Guojun Yin, Yuzhong Ma. Regulatory effects of Glycyrrhiza total flavones on fatty liver injury induced by a high-fat diet in tilapia (Oreochromis niloticus) via the Nrf2 and TLR signaling pathwaysAquaculture International 2022; 30(3): 1527 doi: 10.1007/s10499-021-00787-2
73
Hiroshi Fukui. Gut Microbiota and Host Reaction in Liver DiseasesMicroorganisms 2015; 3(4): 759 doi: 10.3390/microorganisms3040759
74
Sana Raza, Archana Tewari, Sangam Rajak, Rohit A. Sinha. Vitamins and non-alcoholic fatty liver disease: A molecular insightLiver Research 2021; 5(2): 62 doi: 10.1016/j.livres.2021.03.004
75
Meng-yang Qu, Yan-fang Pan, Min Xie, K.H.M. Mansur, Y. Fu. Research progress of intestinal microecology in the occurrence and development of precancerous lesions of liverE3S Web of Conferences 2021; 251: 02046 doi: 10.1051/e3sconf/202125102046
76
Peter Wilhelmsson. Integrative and Functional Medical Nutrition Therapy2020; : 595 doi: 10.1007/978-3-030-30730-1_35
77
Laia Bertran, Marta Portillo-Carrasquer, Salomé Martínez, Carmen Aguilar, Miguel Lopez-Dupla, David Riesco, Jessica Binetti, Margarita Vives, Fàtima Sabench, Daniel Del Castillo, Cristóbal Richart, Teresa Auguet. Expression of Jejunal Taste Receptors in Women with Morbid ObesityNutrients 2021; 13(7): 2437 doi: 10.3390/nu13072437
78
Thomas Greuter, Harmeet Malhi, Gregory J. Gores, Vijay H. Shah. Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesisJCI Insight 2017; 2(17) doi: 10.1172/jci.insight.95354
79
Qi Li, Jiawei Gao, Jiashun Luo, Dihui Lin, Xinrui Wu. Mendelian randomization analyses support causal relationship between gut microbiota and childhood obesityFrontiers in Pediatrics 2023; 11 doi: 10.3389/fped.2023.1229236
80
Gang Xu, Yu-Min Wang, Miao-Miao Ying, Sui-Dan Chen, Zong-Rui Li, Hong-Lei Ma, Ming-Hua Zheng, Jian Wu, Chunming Ding. Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitisClinical and Molecular Hepatology 2021; 27(2): 329 doi: 10.3350/cmh.2020.0261
81
Amedeo Lonardo, Fabio Nascimbeni, Giovanni Targher, Mauro Bernardi, Ferruccio Bonino, Elisabetta Bugianesi, Alessandro Casini, Amalia Gastaldelli, Giulio Marchesini, Fabio Marra, Luca Miele, Filomena Morisco, Salvatore Petta, Fabio Piscaglia, Gianluca Svegliati-Baroni, Luca Valenti, Stefano Bellentani. AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directionsDigestive and Liver Disease 2017; 49(5): 471 doi: 10.1016/j.dld.2017.01.147
82
Michelle L Boland, Denise Oró, Kirstine S Tølbøl, Sebastian T Thrane, Jens Christian Nielsen, Taylor S Cohen, David E Tabor, Fiona Fernandes, Andrey Tovchigrechko, Sanne S Veidal, Paul Warrener, Bret R Sellman, Jacob Jelsing, Michael Feigh, Niels Vrang, James L Trevaskis, Henrik H Hansen. Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat sourceWorld Journal of Gastroenterology 2019; 25(33): 4904-4920 doi: 10.3748/wjg.v25.i33.4904
83
Gianluca Svegliati-Baroni, Bárbara Patrício, Gessica Lioci, Maria Paula Macedo, Amalia Gastaldelli. Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASHInternational Journal of Molecular Sciences 2020; 21(16): 5820 doi: 10.3390/ijms21165820
84
Mikkel Breinholt Kjær, Jacob George, Konstantin Kazankov, Henning Grønbæk. Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy?Expert Review of Gastroenterology & Hepatology 2021; 15(1): 51 doi: 10.1080/17474124.2020.1817740
85
Chencheng Xie, Christine Pocha. Crosstalk between Gut Microbiota and Hepatocellular CarcinomaGastrointestinal Disorders 2023; 5(2): 127 doi: 10.3390/gidisord5020013
86
Parth J Parekh, Luis A Balart, David A Johnson. The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal DiseaseClinical and Translational Gastroenterology 2015; 6(6): e91 doi: 10.1038/ctg.2015.16
87
Mingfei Yao, Lingling Qv, Yanmeng Lu, Baohong Wang, Björn Berglund, Lanjuan Li. An Update on the Efficacy and Functionality of Probiotics for the Treatment of Non-Alcoholic Fatty Liver DiseaseEngineering 2021; 7(5): 679 doi: 10.1016/j.eng.2020.01.017
88
Yong Jiang, Tao Han, Zhi‐Guang Zhang, Man Li, Feng‐Xiang Qi, Ying Zhang, Ying‐Lan Ji. Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver diseaseChronic Diseases and Translational Medicine 2017; 3(3): 165 doi: 10.1016/j.cdtm.2017.06.003
89
Stefano Bibbò, Gianluca Ianiro, Maria Pina Dore, Claudia Simonelli, Estelle E. Newton, Giovanni Cammarota. Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver DiseaseMediators of Inflammation 2018; 2018: 1 doi: 10.1155/2018/9321643
90
Noha F. Hassan, Somaia A. Nada, Azza Hassan, Mona R. El-Ansary, Muhammad Y. Al-Shorbagy, Rania M. Abdelsalam. Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic SteatohepatitisInflammation 2019; 42(3): 1056 doi: 10.1007/s10753-019-00967-6
91
Yun Ji, Yue Yin, Ziru Li, Weizhen Zhang. Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD)Nutrients 2019; 11(8): 1712 doi: 10.3390/nu11081712
92
Yi Xia, Mengting Ren, Jinpu Yang, Changzhou Cai, Weixin Cheng, Xinxin Zhou, Dan Lu, Feng Ji. Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causalityFrontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.1003755
93
Craig James McClain, Laura Smart, Sarah Safadi, Irina Kirpich. Present Knowledge in Nutrition2020; : 483 doi: 10.1016/B978-0-12-818460-8.00026-5
94
Hamed Ebrahimzadeh Leylabadlo, Sarvin Sanaie, Fatemah Sadeghpour Heravi, Zainab Ahmadian, Reza Ghotaslou. From role of gut microbiota to microbial-based therapies in type 2-diabetesInfection, Genetics and Evolution 2020; 81: 104268 doi: 10.1016/j.meegid.2020.104268
95
Zhongbo Liu, Jose Cordoba-Chacon, Rhonda D. Kineman, Bruce N. Cronstein, Radhika Muzumdar, Zhenwei Gong, Haim Werner, Shoshana Yakar. Growth Hormone Control of Hepatic Lipid MetabolismDiabetes 2016; 65(12): 3598 doi: 10.2337/db16-0649
96
Wang Gu, Kang Wen, Chunchi Yan, Shuo Li, Tongjun Liu, Cheng Xu, Long Liu, Minmeng Zhao, Jun Zhang, Tuoyu Geng, Daoqing Gong. Maintaining intestinal structural integrity is a potential protective mechanism against inflammation in goose fatty liverPoultry Science 2020; 99(11): 5297 doi: 10.1016/j.psj.2020.08.052
97
Tian-Hui Gao, Wan Liao, Li-Ting Lin, Zong-Ping Zhu, Mei-Gui Lu, Chao-Mei Fu, Tian Xie. Curcumae rhizoma and its major constituents against hepatobiliary disease: Pharmacotherapeutic properties and potential clinical applicationsPhytomedicine 2022; 102: 154090 doi: 10.1016/j.phymed.2022.154090
98
Shuhua Shen, Kungen Wang, Yihui Zhi, Wei Shen, Liquan Huang. Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS/TLR4 signaling pathwayCell Cycle 2020; 19(22): 3042 doi: 10.1080/15384101.2020.1829800
99
Luca Maroni, Francesca Fianchi, Luca Miele, Gianluca Svegliati Baroni. The Complex Interplay Between Gut-Brain, Gut-Liver, and Liver-Brain Axes2021; : 97 doi: 10.1016/B978-0-12-821927-0.00002-4
100
O. S. Oynotkinova, E. L. Nikonov, T. Y. Demidova, A. P. Baranov, E. V. Kryukov, E. I. Dedov, E. A. Karavashkina. Changes in the intestinal microbiota as a risk factor for dyslipidemia, atherosclerosis and the role of probiotics in their preventionTerapevticheskii arkhiv 2020; 92(9): 94 doi: 10.26442/00403660.2020.09.000784
101
Zofia Prokopowicz, Ewa Malecka-Tendera, Pawel Matusik. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese ChildrenCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/9465784
102
Chencheng Xie, Dina Halegoua-DeMarzio. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?Nutrients 2019; 11(11): 2837 doi: 10.3390/nu11112837
103
Masum M. Mia, Manvendra K. Singh. Emerging roles of the Hippo signaling pathway in modulating immune response and inflammation‐driven tissue repair and remodelingThe FEBS Journal 2022; 289(14): 4061 doi: 10.1111/febs.16449
104
Nádia Duarte, Inês C. Coelho, Rita S. Patarrão, Joana I. Almeida, Carlos Penha-Gonçalves, M. Paula Macedo. How Inflammation Impinges on NAFLD: A Role for Kupffer CellsBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/984578
105
Lijun Wang, Weiwei Zhou, Manyun Guo, Yiming Hua, Baihua Zhou, Xinyin Li, Xinxin Zhang, Jiakun Dong, Xiumei Yang, Yang Wang, Yue Wu, Jianqing She, Jianjun Mu. The gut microbiota is associated with clinical response to statin treatment in patients with coronary artery diseaseAtherosclerosis 2021; 325: 16 doi: 10.1016/j.atherosclerosis.2021.03.007
106
Jacques Delarue, Jean‐Paul Lallès. Nonalcoholic fatty liver disease: Roles of the gut and the liver and metabolic modulation by some dietary factors and especially long‐chain n‐3 PUFAMolecular Nutrition & Food Research 2016; 60(1): 147 doi: 10.1002/mnfr.201500346
107
Natalia Nuño-Lámbarri, Norberto C. Chávez-Tapia, Misael Uribe. Encyclopedia of Food Chemistry2019; : 387 doi: 10.1016/B978-0-08-100596-5.21759-9
108
Wei Song, Tianyi Wang, Xiaole Cui, Lingling Li, Bing Chen, Yanjie Li, Tianli Yue. Lactobacillus coryniformis subsp. torquensT3 alleviates non‐alcoholic fatty liver disease via reconstruction of the gut microbiota and redox systemJournal of the Science of Food and Agriculture 2023; 103(14): 6814 doi: 10.1002/jsfa.12774
109
Cynthia Aparecida de Castro, Manoela Maciel dos Santos Dias, Karina Ana da Silva, Sandra Aparecida dos Reis, Lisiane Lopes da Conceição, Letícia De Nadai Marcon, Luis Fernando de Sousa Moraes, Maria do Carmo Gouveia Peluzio. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2017; : 129 doi: 10.1007/978-94-007-7675-3_1
110
Miaoqing Ye, Yinghui Tang, Jinyu He, Yueqing Yang, Xueyan Cao, Shaojie Kou, Lin Wang, Lingli Sheng, Jingdong Xue. Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathwayClínica e Investigación en Arteriosclerosis (English Edition) 2021; 33(5): 257 doi: 10.1016/j.artere.2021.09.001
111
Chunwei Cheng, Jun Tan, Wei Qian, Lei Zhang, Xiaohua Hou. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunctionLife Sciences 2018; 209: 157 doi: 10.1016/j.lfs.2018.08.017
112
Branka Filipovic, Snezana Lukic, Dragana Mijac, Marija Marjanovic-Haljilji, Marko Vojnovic, Jelena Bogdanovic, Tijana Glisic, Natasa Filipovic, Jamal Al Kiswani, Aleksandra Djokovic, Suncica Kapor, Slobodan Kapor, Zoran Bukumiric, Ana Starcevic. The New Therapeutic Approaches in the Treatment of Non-Alcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2021; 22(24): 13219 doi: 10.3390/ijms222413219
113
Jianyi Calvin Koh, Wai Mun Loo, Khean Lee Goh, Kentaro Sugano, Wah Kheong Chan, Wai Yan Philip Chiu, Myung‐Gyu Choi, Sutep Gonlachanvit, Wei‐Jei Lee, Wei Jie Jonathan Lee, Yeong Yeh Lee, Laurentius A Lesmana, You‐Ming Li, Chun Jen Liu, Bunzo Matsuura, Atsushi Nakajima, Enders Kwok Wai Ng, Jose D Sollano, Simon Kin Hung Wong, Vincent W S Wong, Yunsheng Yang, Khek Yu Ho, Yock Young Dan. Asian consensus on the relationship between obesity and gastrointestinal and liver diseasesJournal of Gastroenterology and Hepatology 2016; 31(8): 1405 doi: 10.1111/jgh.13385
114
Benedikt Kaufmann, Nick Seyfried, Daniel Hartmann, Phillipp Hartmann. Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver diseaseAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2023; 325(1): G42 doi: 10.1152/ajpgi.00017.2023
115
José Manuel Rubio-Gómez, Carlos Molina Santiago, Zulema Udaondo, Mireia Tena Garitaonaindia, Tino Krell, Juan-Luis Ramos, Abdelali Daddaoua. Full Transcriptomic Response of Pseudomonas aeruginosa to an Inulin-Derived FructooligosaccharideFrontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.00202
116
Xiao-Jing Zhang, Peng Zhang, Hongliang Li. Interferon Regulatory Factor Signalings in Cardiometabolic DiseasesHypertension 2015; 66(2): 222 doi: 10.1161/HYPERTENSIONAHA.115.04898
117
Dandan Tian, Yihan Yu, Yingying Yu, Lingzheng Lu, Difei Tong, Weixia Zhang, Xunyi Zhang, Wei Shi, Guangxu Liu. Tris(2-chloroethyl) Phosphate Exerts Hepatotoxic Impacts on Zebrafish by Disrupting Hypothalamic–Pituitary–Thyroid and Gut–Liver AxesEnvironmental Science & Technology 2023; 57(24): 9043 doi: 10.1021/acs.est.3c01631
118
Simona Iacob, Diana Gabriela Iacob. Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: DysbiosisFrontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.01676
119
Esther Nistal, Luis E. Sáenz de Miera, María Ballesteros Pomar, Sonia Sánchez Campos, María Victoria García Mediavilla, Begoña Álvarez Cuenllas, Pedro Linares, José Luis Olcoz, María Teresa Arias Loste, Juan María García Lobo, Javier Crespo, Javier González Gallego, Francisco Jorquera Plaza. An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesityRevista Española de Enfermedades Digestivas 2019; 111 doi: 10.17235/reed.2019.6068/2018
120
Swadha Anand, Sharmila S. Mande. Host-microbiome interactions: Gut-Liver axis and its connection with other organsnpj Biofilms and Microbiomes 2022; 8(1) doi: 10.1038/s41522-022-00352-6
121
Parneet Kaur, LisaF.M LeeNenThat, Saurabh Kulshreshtha, Jessica Pandohee. The Gut Microbiota in Health and Disease2023; : 143 doi: 10.1002/9781119904786.ch13
122
Xiao-Lin Liu, Ya-Nan Ming, Jing-Yi Zhang, Xiao-Yu Chen, Min-De Zeng, Yi-Min Mao. Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypesExperimental & Molecular Medicine 2017; 49(1): e283 doi: 10.1038/emm.2016.123
123
Gaolong Zhong, Fang Wan, Juan Lan, Xuanxuan Jiang, Shaofeng Wu, Jiaqiang Pan, Zhaoxin Tang, Lianmei Hu. Arsenic exposure induces intestinal barrier damage and consequent activation of gut-liver axis leading to inflammation and pyroptosis of liver in ducksScience of The Total Environment 2021; 788: 147780 doi: 10.1016/j.scitotenv.2021.147780
124
Fei Wang, Nan‐nan Sun, Lan‐lan Li, Wan‐wan Zhu, Jianbo Xiu, Yan Shen, Qi Xu. Hepatic progenitor cell activation is induced by the depletion of the gut microbiome in miceMicrobiologyOpen 2019; 8(10) doi: 10.1002/mbo3.873
125
Irene Pierantonelli, Gianluca Svegliati-Baroni. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASHTransplantation 2019; 103(1): e1 doi: 10.1097/TP.0000000000002480
126
Chunyu Guo, Qingjun Li, Rihong Chen, Wenhui Fan, Xin Zhang, Yuqian Zhang, Lanping Guo, Xiao Wang, Xinyan Qu, Hongjing Dong. Baicalein alleviates non-alcoholic fatty liver disease in mice by ameliorating intestinal barrier dysfunctionFood & Function 2023; 14(4): 2138 doi: 10.1039/D2FO03015B
127
Kwang Hwa Jung, Wonbeak Yoo, Heather L. Stevenson, Dipti Deshpande, Hong Shen, Mihai Gagea, Suk-Young Yoo, Jing Wang, T. Kris Eckols, Uddalak Bharadwaj, David J. Tweardy, Laura Beretta. Multifunctional Effects of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma in MiceClinical Cancer Research 2017; 23(18): 5537 doi: 10.1158/1078-0432.CCR-16-2253
128
Sebastian J. Wallace, Frank Tacke, Robert F. Schwabe, Neil C. Henderson. Understanding the cellular interactome of non-alcoholic fatty liver diseaseJHEP Reports 2022; 4(8): 100524 doi: 10.1016/j.jhepr.2022.100524
129
Laia Bertran, Rosa Jorba-Martin, Andrea Barrientos-Riosalido, Marta Portillo-Carrasquer, Carmen Aguilar, David Riesco, Salomé Martínez, Margarita Vives, Fàtima Sabench, Daniel Del Castillo, Cristóbal Richart, Teresa Auguet. New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2022; 23(13): 7442 doi: 10.3390/ijms23137442
130
Victor Hugo Dantas Guimarães, Barbhara Mota Marinho, Daisy Motta-Santos, Gabriela da Rocha Lemos Mendes, Sérgio Henrique Sousa Santos. Nutritional implications in the mechanistic link between the intestinal microbiome, renin-angiotensin system, and the development of obesity and metabolic syndromeThe Journal of Nutritional Biochemistry 2023; 113: 109252 doi: 10.1016/j.jnutbio.2022.109252
131
Arpita Arora, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Saurabh Bhatia, Eduardo Sobarzo-Sanchez, Simona Bungau. Unravelling the involvement of gut microbiota in type 2 diabetes mellitusLife Sciences 2021; 273: 119311 doi: 10.1016/j.lfs.2021.119311
132
Ting Qiu, Weitao Hu, Zilan Rao, Taiyong Fang. The molecular basis of the associations between non-alcoholic fatty liver disease and colorectal cancerFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.1007337
133
Laura J. Craven, Seema Nair Parvathy, Jeremy P. Burton, Michael S. Silverman. Response to Ianiro et al.American Journal of Gastroenterology 2021; 116(6): 1361 doi: 10.14309/ajg.0000000000001160
134
Elizabeth C Verna. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIVThe Lancet Gastroenterology & Hepatology 2017; 2(3): 211 doi: 10.1016/S2468-1253(16)30120-0
135
Asmaa M. Elshaer, Omnyah A. El-kharashi, Ghada Galal Hamam, Enas S. Nabih, Yosra M. Magdy, Abeer A. Abd El Samad. Involvement of TLR4/ CXCL9/ PREX-2 pathway in the development of hepatocellular carcinoma (HCC) and the promising role of early administration of lactobacillus plantarum in Wistar ratsTissue and Cell 2019; 60: 38 doi: 10.1016/j.tice.2019.07.010
136
Wangxin Liu, Xianliang Luo, Jun Tang, Qiufen Mo, Hao Zhong, Hui Zhang, Fengqin Feng. A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrierEuropean Journal of Nutrition 2021; 60(5): 2317 doi: 10.1007/s00394-020-02431-w
137
Noha F. Hassan, Azza H. Hassan, Mona R. El-Ansary. Cytokine modulation by etanercept ameliorates metabolic syndrome and its related complications induced in rats administered a high-fat high-fructose dietScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-24593-9
138
B. Fatemeh Nobakht M. Gh, Yazdan Hasani Nourian, Masoud Arabfard. Identification of Shared Gene Signatures in Different Stages of Nonalcoholic Fatty Liver Disease Using Integrated Microarray DatasetsHepatitis Monthly 2022; 22(1) doi: 10.5812/hepatmon-122362
139
Chenwei Song, Wei Lv, Yahui Li, Pan Nie, Jun Lu, Yanlou Geng, Zhang Heng, Lihua Song. Alleviating the effect of quinoa and the underlying mechanism on hepatic steatosis in high-fat diet-fed ratsNutrition & Metabolism 2021; 18(1) doi: 10.1186/s12986-021-00631-7
140
Miaoqing Ye, Yinghui Tang, Jinyu He, Yueqing Yang, Xueyan Cao, Shaojie Kou, Lin Wang, Lingli Sheng, Jingdong Xue. Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathwayClínica e Investigación en Arteriosclerosis 2021; 33(5): 257 doi: 10.1016/j.arteri.2020.12.007
141
Jung A Eom, Goo Hyun Kwon, Na Yeon Kim, Eun Ju Park, Sung Min Won, Jin Ju Jeong, Ganesan Raja, Haripriya Gupta, Yoseph Asmelash Gebru, Satyapriya Sharma, Ye Rin Choi, Hyeong Seop Kim, Sang Jun Yoon, Ji Ye Hyun, Min Kyo Jeong, Hee Jin Park, Byeong Hyun Min, Mi Ran Choi, Dong Joon Kim, Ki Tae Suk. Diet-Regulating Microbiota and Host Immune System in Liver DiseaseInternational Journal of Molecular Sciences 2021; 22(12): 6326 doi: 10.3390/ijms22126326
142
Shengan Zhang, Yanqi Dang. Roles of gut microbiota and metabolites in overweight and obesity of childrenFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.994930
143
Meiyu Jin, Lianwen Zheng, Yunfei Wei, Jiaqi Cheng, Di Zhang, Siru Yan, Haiyan Qin, Qi Wang, Xinxin Ci, Haihua Feng. Enterobacter cloacae aggravates metabolic disease by inducing inflammation and lipid accumulationEnvironmental Toxicology and Pharmacology 2022; 90: 103819 doi: 10.1016/j.etap.2022.103819
144
Pablo Muriel. Hepatic Fibrosis2022; : 25 doi: 10.1016/B978-0-323-99764-5.00010-X
145
Muzahir Hussain, Muhammad Umair Ijaz, Muhammad Ijaz Ahmad, Iftikhar Ali Khan, Syed Umar Farooq Bukhary, Waqar Khan, Sayed Hussain, Majid Suhail Hashmi, Chunbao Li. Gut inflammation exacerbates hepatic injury in C57BL/6J mice via gut-vascular barrier dysfunction with high-fat-incorporated meat protein dietsFood & Function 2020; 11(10): 9168 doi: 10.1039/D0FO02153A
146
Wenwen Sun, Jiahao Zhu, Guanyu Qin, Yujie Huang, Siying Cheng, Zhengzhi Chen, Yeyang Zhang, Yifan Shu, Xiaoxiong Zeng, Renpeng Guo. Lonicera japonica polysaccharides alleviate D-galactose-induced oxidative stress and restore gut microbiota in ICR miceInternational Journal of Biological Macromolecules 2023; 245: 125517 doi: 10.1016/j.ijbiomac.2023.125517
147
R.X. Wei, F.J. Ye, F. He, Q. Song, X.P. Xiong, W.L. Yang, X. Gang, J.W. Hu, B. Hu, H.Y. Xu, L. Li, H.H. Liu, X.Y. Zeng, L. Chen, B. Kang, C.C. Han. Comparison of overfeeding effects on gut physiology and microbiota in two goose breedsPoultry Science 2021; 100(3): 100960 doi: 10.1016/j.psj.2020.12.057
148
Tze Mun Loo, Fumitaka Kamachi, Yoshihiro Watanabe, Shin Yoshimoto, Hiroaki Kanda, Yuriko Arai, Yaeko Nakajima-Takagi, Atsushi Iwama, Tomoaki Koga, Yukihiko Sugimoto, Takayuki Ozawa, Masaru Nakamura, Miho Kumagai, Koichi Watashi, Makoto M. Taketo, Tomohiro Aoki, Shuh Narumiya, Masanobu Oshima, Makoto Arita, Eiji Hara, Naoko Ohtani. Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor ImmunityCancer Discovery 2017; 7(5): 522 doi: 10.1158/2159-8290.CD-16-0932
149
Shuwei Zhang, Yui-Tung Wong, Ka-Yu Tang, Hiu-Yee Kwan, Tao Su. Chinese Medicinal Herbs Targeting the Gut–Liver Axis and Adipose Tissue–Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern ScienceFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.572729
150
David Porras, Esther Nistal, Susana Martínez‐Flórez, José Luis Olcoz, Ramiro Jover, Francisco Jorquera, Javier González‐Gallego, María Victoria García‐Mediavilla, Sonia Sánchez‐Campos. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High‐Fat Diet Determine Non‐Alcoholic Fatty Liver Disease Development in Germ‐Free MiceMolecular Nutrition & Food Research 2019; 63(8) doi: 10.1002/mnfr.201800930
151
Jasmeet S. Mokha, Zev H. Davidovics, Kendra Maas, Melissa J. Caimano, Adam Matson. Fecal Microbiomes in Premature Infants With and Without Parenteral Nutrition–Associated CholestasisJournal of Pediatric Gastroenterology and Nutrition 2019; 69(2): 224 doi: 10.1097/MPG.0000000000002352
152
Celeste M. Lavallee, Jayden A. R. MacPherson, Mi Zhou, Yanhua Gao, Pamela R. Wizzard, Paul W. Wales, Justine M. Turner, Benjamin P. Willing. Lipid Emulsion Formulation of Parenteral Nutrition Affects Intestinal Microbiota and Host Responses in Neonatal PigletsJournal of Parenteral and Enteral Nutrition 2017; 41(8): 1301 doi: 10.1177/0148607116662972
153
Yu Tian, Hualin Wang, Fahu Yuan, Na Li, Qiang Huang, Lei He, Limei Wang, Zhiguo Liu. Perilla Oil Has Similar Protective Effects of Fish Oil on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Gut DysbiosisBioMed Research International 2016; 2016: 1 doi: 10.1155/2016/9462571
154
Kouichi Miura, Mitsuaki Ishioka, Shinichiro Minami, Yasuo Horie, Shigetoshi Ohshima, Takashi Goto, Hirohide Ohnishi. Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in MiceJournal of Biological Chemistry 2016; 291(22): 11504 doi: 10.1074/jbc.M115.709048
155
Sanjoy Roychowdhury, Praveen Selvakumar, Gail Cresci. The Role of the Gut Microbiome in Nonalcoholic Fatty Liver DiseaseMedical Sciences 2018; 6(2): 47 doi: 10.3390/medsci6020047
156
Ryan Kurtz, Meghan F. Anderman, Blythe D. Shepard. GPCRs get fatty: the role of G protein-coupled receptor signaling in the development and progression of nonalcoholic fatty liver diseaseAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 320(3): G304 doi: 10.1152/ajpgi.00275.2020
157
Costanza Renata Neri, Serena Scapaticci, Francesco Chiarelli, Cosimo Giannini. Liver Steatosis: A Marker of Metabolic Risk in ChildrenInternational Journal of Molecular Sciences 2022; 23(9): 4822 doi: 10.3390/ijms23094822
158
Kinya Okamoto, Masahiko Koda, Toshiaki Okamoto, Takumi Onoyama, Kenichi Miyoshi, Manabu Kishina, Jun Kato, Shiho Tokunaga, Taka-aki Sugihara, Yuichi Hara, Keisuke Hino, Yoshikazu Murawaki, Gonzalo Carrasco-Avino. A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse ModelPLOS ONE 2016; 11(5): e0154676 doi: 10.1371/journal.pone.0154676
159
Xiuxia Li, Yanping Wang, Yilan Xing, Renxin Xing, Yongsheng Liu, Yinsheng Xu. Changes of gut microbiota during silybin‐mediated treatment of high‐fat diet‐induced non‐alcoholic fatty liver disease in miceHepatology Research 2020; 50(1): 5 doi: 10.1111/hepr.13444
160
Chencheng Xie, Dina Halegoua-DeMarzio. The Role of Gut Microbiome-Targeted Therapy in Nonalcoholic Fatty Liver DiseaseCurrent Hepatology Reports 2020; 19(4): 420 doi: 10.1007/s11901-020-00547-5
161
Patrice Marques, Vera Francisco, Laura Martínez-Arenas, Ângela Carvalho-Gomes, Elena Domingo, Laura Piqueras, Marina Berenguer, Maria-Jesus Sanz. Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2023; 24(3): 2313 doi: 10.3390/ijms24032313
162
Sergio Quesada-Vázquez, Gerard Aragonès, Josep M Del Bas, Xavier Escoté. Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same AxisCells 2020; 9(1): 176 doi: 10.3390/cells9010176
163
Alexandre Villard, Jérôme Boursier, Ramaroson Andriantsitohaina. Microbiota‐derived extracellular vesicles and metabolic syndromeActa Physiologica 2021; 231(4) doi: 10.1111/apha.13600
164
Alia Dadabhai. Integrative Nutrition Therapy2015; : 375 doi: 10.1201/b18833-17
165
WenJie Yang, Abdur Rahman Ansari, XiaoYu Niu, WeiHua Zou, MengQi Lu, Ling Dong, Fan Li, YanHong Chen, KeLi Yang, Hui Song. Interaction between gut microbiota dysbiosis and lung infection as gut-lung axis caused by Streptococcus suis in mouse modelMicrobiological Research 2022; 261: 127047 doi: 10.1016/j.micres.2022.127047
166
Y. Ilan. Review article: novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppressionAlimentary Pharmacology & Therapeutics 2016; 44(11-12): 1168 doi: 10.1111/apt.13833
167
Jiahuan Li, Xiaoling Deng, Tao Bai, Shuhan Wang, Qianqian Jiang, Keshu Xu. Resolvin D1 mitigates non-alcoholic steatohepatitis by suppressing the TLR4-MyD88‐mediated NF‐κB and MAPK pathways and activating the Nrf2 pathway in miceInternational Immunopharmacology 2020; 88: 106961 doi: 10.1016/j.intimp.2020.106961
168
Branka Filipovic, Marija Marjanovic-Haljilji, Dragana Mijac, Snezana Lukic, Suncica Kapor, Slobodan Kapor, Ana Starcevic, Dusan Popovic, Aleksandra Djokovic. Molecular Aspects of MAFLD—New Insights on Pathogenesis and TreatmentCurrent Issues in Molecular Biology 2023; 45(11): 9132 doi: 10.3390/cimb45110573
169
Rui Jia, Li-Ping Cao, Jin-Liang Du, Qin He, Zheng-Yan Gu, Galina Jeney, Pao Xu, Guo-Jun Yin. Effects of high-fat diet on antioxidative status, apoptosis and inflammation in liver of tilapia (Oreochromis niloticus) via Nrf2, TLRs and JNK pathwaysFish & Shellfish Immunology 2020; 104: 391 doi: 10.1016/j.fsi.2020.06.025
170
Wei Song, Li-Ying Sun, Zhi-Jun Zhu, Lin Wei, Wei Qu, Zhi-Gui Zeng, Yun-Sheng Yang. Characteristics of Gut Microbiota in Children With Biliary Atresia After Liver TransplantationFrontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.704313
171
Geoffrey C. Farrell, Fahrettin Haczeyni, Shivakumar Chitturi. Obesity, Fatty Liver and Liver CancerAdvances in Experimental Medicine and Biology 2018; 1061: 19 doi: 10.1007/978-981-10-8684-7_3
172
Rigaiqiqige Sa, Chi Feng, Hongxia Bai, Xiaoyu Yin, Lei Song, Xiaodong Hu, Rui Xu, Xinshan Li, Wu Dong, Jingfeng Yang, Jelena Zivkovic. Inhibitory Effects of Mongolian Medicine Yihe-Tang on Continuous Darkness Induced Liver Steatosis in ZebrafishEvidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/5794655
173
Rabab Fouad Emam, Ahmed Fouad Soliman, Samar Kamal Darweesh, Reham AbdElmoniem AbdElmagid, Ola Mohamed Ibrahim, Dina Mahmoud Mohamed. Steatosis regression assessed by cap after Vitamin ‘D’ supplementation in NAFLD patients with Vitamin ‘D’ deficiencyEuropean Journal of Gastroenterology & Hepatology 2024; 36(1): 101 doi: 10.1097/MEG.0000000000002653
174
Ahmed M. Samy, Mohamed A. Kandeil, Dina Sabry, A. A. Abdel‐Ghany, Mohamed O. Mahmoud. Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathwayArchiv der Pharmazie 2024;  doi: 10.1002/ardp.202300631
175
Jiang Du, Yu Ji, Liang Qiao, Yanli Liu, Juntang Lin. Cellular endo‐lysosomal dysfunction in the pathogenesis of non‐alcoholic fatty liver diseaseLiver International 2020; 40(2): 271 doi: 10.1111/liv.14311
176
Katharina Brandl, Bernd Schnabl. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?Expert Review of Gastroenterology & Hepatology 2015; 9(8): 1069 doi: 10.1586/17474124.2015.1057122
177
Gao-Xin Xu, Song Wei, Chao Yu, Si-Qi Zhao, Wei-Jun Yang, Yong-Heng Feng, Chao Pan, Kun-Xing Yang, Yong Ma. Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventionsFrontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1199519
178
Safak Kiziltas. Toll-like receptors in pathophysiology of liver diseasesWorld Journal of Hepatology 2016; 8(32): 1354-1369 doi: 10.4254/wjh.v8.i32.1354
179
Dabin Jeon, Vineet Singh, Tatsuya Unno. In vitro investigation of food effects on human gut microbiotaJournal of Applied Biological Chemistry 2021; 64(1): 75 doi: 10.3839/jabc.2021.012
180
Hiroshi Fukui. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?Diseases 2019; 7(4): 58 doi: 10.3390/diseases7040058
181
Alix Bruneau, Jana Hundertmark, Adrien Guillot, Frank Tacke. Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver DiseasesFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.725390
182
Ya. M. Vakhrushev, A. P. Lukashevich, E. V. Suchkova. ASSOCIATION OF INTESTINAL BACTERIAL OVERGROWTH AND DISEASES OF HEPATOBIARY TRACTThe Russian Archives of Internal Medicine 2019; 9(1): 64 doi: 10.20514/2226-6704-2019-9-1-64-69
183
Danni Qu, Mengyun Chen, Haiyan Zhu, Xingyu Liu, Yanan Cui, Wei Zhou, Min Zhang. Akkermansia muciniphila and its outer membrane protein Amuc_1100 prevent high-fat diet-induced nonalcoholic fatty liver disease in miceBiochemical and Biophysical Research Communications 2023; 684: 149131 doi: 10.1016/j.bbrc.2023.149131
184
Mariana Verdelho Machado, Anna Mae Diehl. Pathogenesis of Nonalcoholic SteatohepatitisGastroenterology 2016; 150(8): 1769 doi: 10.1053/j.gastro.2016.02.066
185
Eman Kolieb, Shymaa Ahmed Maher, Mohammed Nader Shalaby, Amnah Mohammed Alsuhaibani, Afaf Alharthi, Wael A. Hassan, Karima El-Sayed. Vitamin D and Swimming Exercise Prevent Obesity in Rats under a High-Fat Diet via Targeting FATP4 and TLR4 in the Liver and Adipose TissueInternational Journal of Environmental Research and Public Health 2022; 19(21): 13740 doi: 10.3390/ijerph192113740
186
Erica Vetrano, Luca Rinaldi, Andrea Mormone, Chiara Giorgione, Raffaele Galiero, Alfredo Caturano, Riccardo Nevola, Raffaele Marfella, Ferdinando Carlo Sasso. Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic StrategiesBiomedicines 2023; 11(2): 468 doi: 10.3390/biomedicines11020468
187
Eric Zhao, Christopher Tait, Carlos D. Minacapelli, Carolyn Catalano, Vinod K. Rustgi. Circadian Rhythms, the Gut Microbiome, and Metabolic DisordersGastro Hep Advances 2022; 1(1): 93 doi: 10.1016/j.gastha.2021.10.008
188
Jhon Edison Prieto Ortíz, Carlos Bernardo Sánchez Luque, Rolando José Ortega Quiróz. Hígado graso (parte 1): aspectos generales, epidemiología, fisiopatología e historia naturalRevista colombiana de Gastroenterología 2022; 37(4): 420 doi: 10.22516/25007440.952
189
Hamed Ebrahimzadeh Leylabadlo, Reza Ghotaslou, Hossein Samadi Kafil, Mohammad Mehdi Feizabadi, Seyed Yaghoub Moaddab, Safar Farajnia, Elham Sheykhsaran, Sarvin Sanaie, Dariush Shanehbandi, Hossein Bannazadeh Baghi. Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapiesEuropean Journal of Clinical Microbiology & Infectious Diseases 2020; 39(4): 613 doi: 10.1007/s10096-019-03746-1
190
Shuhua Shen, Kungen Wang, Yihui Zhi, Yue Dong. Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear factor kappa B pathwaysPharmaceutical Biology 2022; 60(1): 1949 doi: 10.1080/13880209.2022.2126503
191
Qihan Wang, Qifan Lu, Wentao Shao, Zhaoyan Jiang, Hai Hu. Dysbiosis of gut microbiota after cholecystectomy is associated with non‐alcoholic fatty liver disease in miceFEBS Open Bio 2021; 11(8): 2329 doi: 10.1002/2211-5463.13243
192
Linlin Chen, Juntao Kan, Ningning Zheng, Bingbing Li, Ying Hong, Juan Yan, Xin Tao, Gaosong Wu, Junli Ma, Weize Zhu, Lili Sheng, Liang Chen, Bo Li, Jing Zhong, Jun Du, Houkai Li. A botanical dietary supplement from white peony and licorice attenuates nonalcoholic fatty liver disease by modulating gut microbiota and reducing inflammationPhytomedicine 2021; 91: 153693 doi: 10.1016/j.phymed.2021.153693
193
Ya M Vakhrushev, E V Suchkova, A P Lukashevich. Non - alcoholic fatty liver disease and enteral insufficiency: comorbidity of their developmentTerapevticheskii arkhiv 2019; 91(12): 84 doi: 10.26442/00403660.2019.12.000134
194
Ratnadeep Bhattacharjee, Kalyani Pathak, Jyotirmoy Das, Smita Bordoloi, Manash Pratim Pathak, Pervej Alom Barbhuiya, Riya Saikia. Therapeutic Potential of Gut Microbiota in Child HealthAnti-Infective Agents 2023; 21(4) doi: 10.2174/2211352521666230518115214
195
Che-Sheng Pai, Cheng-Yuan Wang, Wei-Wen Hung, Wei-Chun Hung, Hui-Ju Tsai, Chen-Chia Chang, Shang-Jyh Hwang, Chia-Yen Dai, Wen-Yu Ho, Yi-Chun Tsai. Interrelationship of Gut Microbiota, Obesity, Body Composition and Insulin Resistance in Asians with Type 2 Diabetes MellitusJournal of Personalized Medicine 2022; 12(4): 617 doi: 10.3390/jpm12040617
196
Lu Wang, Bing Zhao, Ying Chen, Li Ma, Er-Zhen Chen, En-Qiang Mao. Biliary tract external drainage protects against intestinal barrier injury in hemorrhagic shock ratsWorld Journal of Gastroenterology 2015; 21(45): 12800-12813 doi: 10.3748/wjg.v21.i45.12800
197
Zeinab Harb, Valérie Deckert, Aude Marchal Bressenot, Christo Christov, Rosa-Maria Guéant-Rodriguez, Jérémie Raso, Jean Marc Alberto, Jean-Paul Pais de Barros, Remy Umoret, Laurent Peyrin-Biroulet, Laurent Lagrost, Jean-Pierre Bronowicki, Jean-Louis Guéant. The deficit in folate and vitamin B12 triggers liver macrovesicular steatosis and inflammation in rats with dextran sodium sulfate-induced colitisThe Journal of Nutritional Biochemistry 2020; 84: 108415 doi: 10.1016/j.jnutbio.2020.108415
198
Serena Scapaticci, Annamaria Venanzi, Francesco Chiarelli, Cosimo Giannini. MAFLD and Celiac Disease in ChildrenInternational Journal of Molecular Sciences 2023; 24(2): 1764 doi: 10.3390/ijms24021764
199
Yolanda Sanchez-Torrijos, Javier Ampuero, Manuel Romero-Gómez. Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should doWorld Journal of Hepatology 2017; 9(15): 697-703 doi: 10.4254/wjh.v9.i15.697
200
R. Wei, C. Han, D. Deng, F. Ye, X. Gan, H. Liu, L. Li, H. Xu, S. Wei. Research progress into the physiological changes in metabolic pathways in waterfowl with hepatic steatosisBritish Poultry Science 2021; 62(1): 118 doi: 10.1080/00071668.2020.1812527
201
Donald B. Jump, Kelli A. Lytle, Christopher M. Depner, Sasmita Tripathy. Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver diseasePharmacology & Therapeutics 2018; 181: 108 doi: 10.1016/j.pharmthera.2017.07.007
202
Tatsuo Inamine, Bernd Schnabl. Immunoglobulin A and liver diseasesJournal of Gastroenterology 2018; 53(6): 691 doi: 10.1007/s00535-017-1400-8
203
Daniel Ferraz de Campos Mazo, Rejane Mattar, José Tadeu Stefano, Joyce Matie Kinoshita da Silva-Etto, Márcio Augusto Diniz, Sebastião Mauro Bezerra Duarte, Fabíola Rabelo, Rodrigo Vieira Costa Lima, Priscila Brizolla de Campos, Flair José Carrilho, Claudia P Oliveira. Hypolactasia is associated with insulin resistance in nonalcoholic steatohepatitisWorld Journal of Hepatology 2016; 8(24): 1019-1027 doi: 10.4254/wjh.v8.i24.1019
204
玉杰 李. Relationship between Gut Microbiota and Development and Prognosis of Autoimmune Liver DiseaseAdvances in Clinical Medicine 2022; 12(11): 10814 doi: 10.12677/ACM.2022.12111557
205
José Pedro Portela-Cidade, Marta Borges-Canha, Adelino Ferreira Leite-Moreira, Pedro Pimentel-Nunes. Systematic Review of the Relation Between Intestinal Microbiota and Toll-Like Receptors in the Metabolic Syndrome: What Do We Know So Far?GE Portuguese Journal of Gastroenterology 2015; 22(6): 240 doi: 10.1016/j.jpge.2015.06.001
206
Snigdha Jyoti Das, Sangit Dutta, Diptika Tiwari, Tarun Kr Basumatary, Natasha Kashyap, Manash Pratim Kalita, Sujoy Bose, Purabi Deka Bose. Prognostic value of myeloid differentiation primary response protein 88 in type II diabetes mellitus in non-obese NAFLD: A case-control study from AssamHuman Gene 2024; 39: 201246 doi: 10.1016/j.humgen.2023.201246
207
Shaghayegh Khanmohammadi, Mohammad Shafi Kuchay. Toll-like receptors and metabolic (dysfunction)-associated fatty liver diseasePharmacological Research 2022; 185: 106507 doi: 10.1016/j.phrs.2022.106507
208
Qiaozhu Su, Virender Kumar, Neetu Sud, Ram I. Mahato. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosisAdvanced Drug Delivery Reviews 2018; 129: 54 doi: 10.1016/j.addr.2018.01.009
209
Ahmed Abdel-Razik, Nasser Mousa, Walaa Shabana, Mohamed Refaey, Rasha Elzehery, Rania Elhelaly, Khaled Zalata, Mostafa Abdelsalam, Ahmed A. Eldeeb, Mahmoud Awad, Ayman Elgamal, Ahmed Attia, Niveen El-Wakeel, Waleed Eldars. Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shotEuropean Journal of Gastroenterology & Hepatology 2018; 30(10): 1237 doi: 10.1097/MEG.0000000000001232
210
Massimiliano Cadamuro, Alberto Lasagni, Samantha Sarcognato, Maria Guido, Roberto Fabris, Mario Strazzabosco, Alastair J. Strain, Paolo Simioni, Erica Villa, Luca Fabris. The Neglected Role of Bile Duct Epithelial Cells in NASHSeminars in Liver Disease 2022; 42(01): 034 doi: 10.1055/s-0041-1739455
211
Chen Yan, Cuili Zhang, Xuejiao Cao, Bin Feng, Xinli Li. Intestinal Population in Host with Metabolic Syndrome during Administration of Chitosan and Its DerivativesMolecules 2020; 25(24): 5857 doi: 10.3390/molecules25245857
212
Nicolás Ortiz-López, Catalina Fuenzalida, María Soledad Dufeu, Araceli Pinto-León, Alejandro Escobar, Jaime Poniachik, Juan Pablo Roblero, Lucía Valenzuela-Pérez, Caroll J. Beltrán. The immune response as a therapeutic target in non-alcoholic fatty liver diseaseFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.954869
213
Carlos Sanz-García, Anabel Fernández-Iglesias, Jordi Gracia-Sancho, Luis Alfonso Arráez-Aybar, Yulia A. Nevzorova, Francisco Javier Cubero. The Space of Disse: The Liver Hub in Health and DiseaseLivers 2021; 1(1): 3 doi: 10.3390/livers1010002
214
Junli Ma, Houkai Li. The Role of Gut Microbiota in Atherosclerosis and HypertensionFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01082
215
Eveliina Munukka, Petri Wiklund, Tiina Partanen, Sakari Välimäki, Eija K. Laakkonen, Maarit Lehti, Pamela Fischer-Posovzsky, Martin Wabitsch, Sulin Cheng, Pentti Huovinen, Satu Pekkala, Pratibha V. Nerurkar. Adipocytes as a Link Between Gut Microbiota-Derived Flagellin and Hepatocyte Fat AccumulationPLOS ONE 2016; 11(4): e0152786 doi: 10.1371/journal.pone.0152786
216
Zhiruo Miao, Zhiying Miao, Min Liu, Shiwen Xu. Melatonin ameliorates imidacloprid-induced intestinal injury by negatively regulating the PGN/P38MAPK pathway in the common carp (Cyprinus carpio)Fish & Shellfish Immunology 2022; 131: 1063 doi: 10.1016/j.fsi.2022.11.018
217
Jiazhen Zheng, Ziyi Li, Hengyi Xu. Intestinal Microbiotas and Alcoholic Hepatitis: Pathogenesis and Therapeutic ValueInternational Journal of Molecular Sciences 2023; 24(19): 14809 doi: 10.3390/ijms241914809
218
Ying-Li Liu, Qiu-Zan Zhang, Yan-Rong Wang, Li-Na Fu, Jing-Shu Han, Jing Zhang, Bang-Mao Wang. Astragaloside IV Improves High-Fat Diet–Induced Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Rats by Regulating Inflammatory Factors Level via TLR4/NF-κB Signaling PathwayFrontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.605064
219
Gianluca Svegliati-Baroni, Irene Pierantonelli, Pierangelo Torquato, Rita Marinelli, Carla Ferreri, Chryssostomos Chatgilialoglu, Desirée Bartolini, Francesco Galli. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver diseaseFree Radical Biology and Medicine 2019; 144: 293 doi: 10.1016/j.freeradbiomed.2019.05.029
220
Aoxiang Zhuge, Shengjie Li, Pengcheng Lou, Wenrui Wu, Kaiceng Wang, Yin Yuan, Jiafeng Xia, Bo Li, Lanjuan Li, Yongjun Sui. Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in MiceMicrobiology Spectrum 2022; 10(3) doi: 10.1128/spectrum.00047-22
221
Nasrin Sharifi, Reza Amani. Vitamin D supplementation and non-alcoholic fatty liver disease: A critical and systematic review of clinical trialsCritical Reviews in Food Science and Nutrition 2019; 59(4): 693 doi: 10.1080/10408398.2017.1389693
222
Haichao Wang, Yaying Li, Yifei Bian, Xue Li, Yubei Wang, Ke Wu, Chuanguo Liu, Yuhong Liu, Xiaoming Wang. Potential hepatoprotective effects of Cistanche deserticola Y.C. Ma: Integrated phytochemical analysis using UPLC-Q-TOF-MS/MS, target network analysis, and experimental assessmentFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1018572
223
Kai Schneider, Antje Mohs, Konrad Kilic, Lena Candels, Carsten Elfers, Eveline Bennek, Lukas Schneider, Felix Heymann, Nikolaus Gassler, John Penders, Christian Trautwein. Intestinal Microbiota Protects against MCD Diet-Induced SteatohepatitisInternational Journal of Molecular Sciences 2019; 20(2): 308 doi: 10.3390/ijms20020308
224
Jiashu Li, Zeyang Qu, Feng Liu, Hao Jing, Yu Pan, Siyu Guo, Chun Loong Ho. Principles in Microbiome Engineering2022; : 1 doi: 10.1002/9783527825462.ch1
225
Kinya Okamoto, Masahiko Koda, Toshiaki Okamoto, Takumi Onoyama, Kenichi Miyoshi, Manabu Kishina, Tomomitsu Matono, Jun Kato, Shiho Tokunaga, Takaaki Sugihara, Akira Hiramatsu, Hideyuki Hyogo, Hiroshi Tobita, Shuichi Sato, Miwa Kawanaka, Yuichi Hara, Keisuke Hino, Kazuaki Chayama, Yoshikazu Murawaki, Hajime Isomoto, Catherine Mounier. Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver diseasePLOS ONE 2020; 15(2): e0219412 doi: 10.1371/journal.pone.0219412
226
Parth J. Parekh, Edward C. Oldfield, David A. Johnson. The Effects of Sleep on the Commensal MicrobiotaJournal of Clinical Gastroenterology 2018; 52(3): 204 doi: 10.1097/MCG.0000000000000965
227
Paola Dongiovanni, Raffaela Rametta, Marica Meroni, Luca Valenti. The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development – a potential therapeutic target?Expert Review of Gastroenterology & Hepatology 2016; 10(2): 229 doi: 10.1586/17474124.2016.1110018
228
Simona Alexandra Iacob, Diana Gabriela Iacob. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis BreakdownFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.814209
229
Fernando Bessone, María Valeria Razori, Marcelo G. Roma. Molecular pathways of nonalcoholic fatty liver disease development and progressionCellular and Molecular Life Sciences 2019; 76(1): 99 doi: 10.1007/s00018-018-2947-0
230
Cosimo Giannini, Concetta Mastromauro, Serena Scapaticci, Cristina Gentile, Francesco Chiarelli. Role of bile acids in overweight and obese children and adolescentsFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1011994
231
Marco Poeta, Luca Pierri, Pietro Vajro. Gut–Liver Axis Derangement in Non-Alcoholic Fatty Liver DiseaseChildren 2017; 4(8): 66 doi: 10.3390/children4080066
232
Pietro Torre, Benedetta Maria Motta, Roberta Sciorio, Mario Masarone, Marcello Persico. Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune SystemFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.781567
233
Kyoungsub Song, Hyunjoo Kwon, Chang Han, Weina Chen, Jinqiang Zhang, Wenbo Ma, Srikanta Dash, Chandrashekhar R. Gandhi, Tong Wu. Yes‐Associated Protein in Kupffer Cells Enhances the Production of Proinflammatory Cytokines and Promotes the Development of Nonalcoholic SteatohepatitisHepatology 2020; 72(1): 72 doi: 10.1002/hep.30990
234
Gege Tian, Wei Wang, Enrui Xia, Wenhui Chen, Shunzhen Zhang. Dendrobium officinale alleviates high-fat diet-induced nonalcoholic steatohepatitis by modulating gut microbiotaFrontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1078447
235
Alfredo Larrosa-Haro, Erika A. Caro-Sabido. Secondary Malnutrition and Nutritional Intervention in Cholestatic Liver Diseases in InfantsFrontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.716613
236
C.C. Lu, R.X. Wei, D.H. Deng, Z.Y. Luo, M. Abdulai, H.H. Liu, B. Kang, S.Q. Hu, L. Li, H.Y. Xu, J.W. Hu, S.H. Wei, C.C. Han. Effect of different types of sugar on gut physiology and microbiota in overfed goosePoultry Science 2021; 100(7): 101208 doi: 10.1016/j.psj.2021.101208
237
孟桥 陈. Progress on the Role of “Gutbacteria-Gut-Liver Axis” in Non-Alcoholic Fatty Liver DiseaseMedical Diagnosis 2023; 13(02): 237 doi: 10.12677/MD.2023.132038
238
Hyun Young Kim, Younggap Lim, Ji Sun Jang, Yeon Kyeong Ko, Youngnim Choi, Hong‐Hee Kim, Bong‐Kyu Choi. Extracellular vesicles from periodontal pathogens regulate hepatic steatosis via Toll‐like receptor 2 and plasminogen activator inhibitor‐1Journal of Extracellular Vesicles 2024; 13(1) doi: 10.1002/jev2.12407
239
Mohsen Mazidi, Niki Katsiki, Dimitri P. Mikhailidis, Maciej Banach. Adiposity May Moderate the Link Between Choline Intake and Non-alcoholic Fatty Liver DiseaseJournal of the American College of Nutrition 2019; 38(7): 633 doi: 10.1080/07315724.2018.1507011
240
Thomas Ritz, Oliver Krenkel, Frank Tacke. Dynamic plasticity of macrophage functions in diseased liverCellular Immunology 2018; 330: 175 doi: 10.1016/j.cellimm.2017.12.007
241
Shu-Hua Shen, Ting-Yan Zhong, Cui Peng, Jie Fang, Bin Lv. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in ratsBMC Complementary Medicine and Therapies 2020; 20(1) doi: 10.1186/s12906-020-2835-7
242
Junli Ma, Qihang Zhou, Houkai Li. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and TherapyNutrients 2017; 9(10): 1124 doi: 10.3390/nu9101124
243
Francesca Fianchi, Antonio Liguori, Antonio Gasbarrini, Antonio Grieco, Luca Miele. Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized TherapyInternational Journal of Molecular Sciences 2021; 22(12): 6485 doi: 10.3390/ijms22126485
244
Lijun Wang, Yu-Jui Yvonne Wan. The role of gut microbiota in liver disease development and treatmentLiver Research 2019; 3(1): 3 doi: 10.1016/j.livres.2019.02.001
245
Athina I. Amanatidou, George V. Dedoussis. Construction and analysis of protein-protein interaction network of non-alcoholic fatty liver diseaseComputers in Biology and Medicine 2021; 131: 104243 doi: 10.1016/j.compbiomed.2021.104243
246
Sahar Y. Al-Okbi, Magdy A. Amin, Amal E. A. Mohamed, Amr E. Edris, Osama M. Sharaf, Hoda B Mabrok, Asmaa A. Ramadan. Basil Essential Oil and Its Nanoemulsion Mitigate Non Alcoholic Steatohepatitis in Rat Model with Special Reference to Gut MicrobiotaJournal of Oleo Science 2020; 69(8): 913 doi: 10.5650/jos.ess20067
247
Mariana Verdelho Machado, Anna Mae Diehl. Zakim and Boyer's Hepatology2018; : 369 doi: 10.1016/B978-0-323-37591-7.00025-2
248
Jing Xiong, Xia Chen, Zhijing Zhao, Ying Liao, Ting Zhou, Qian Xiang. A potential link between plasma short‑chain fatty acids, TNF‑α level and disease progression in non‑alcoholic fatty liver disease: A retrospective studyExperimental and Therapeutic Medicine 2022; 24(3) doi: 10.3892/etm.2022.11536
249
Veronika Vyletelová, Mária Nováková, Ľudmila Pašková. Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted TherapiesPharmaceuticals 2022; 15(10): 1278 doi: 10.3390/ph15101278
250
Felipe Pinheiro de Oliveira, Roberta Hack Mendes, Priscila Thiago Dobbler, Volker Mai, Victor Salter Pylro, Sheldon G Waugh, Filippo Vairo, Lilia Farret Refosco, Luiz Fernando Würdig Roesch, Ida Vanessa Doederlein Schwartz, Brenda A Wilson. Phenylketonuria and Gut Microbiota: A Controlled Study Based on Next-Generation SequencingPLOS ONE 2016; 11(6): e0157513 doi: 10.1371/journal.pone.0157513
251
Kavita Jadhav, Taylor S. Cohen. Can You Trust Your Gut? Implicating a Disrupted Intestinal Microbiome in the Progression of NAFLD/NASHFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.592157
252
Ayse L. Mindikoglu, Antone R. Opekun, Sood K. Gagan, Sridevi Devaraj. Impact of Time-Restricted Feeding and Dawn-to-Sunset Fasting on Circadian Rhythm, Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver DiseaseGastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/3932491
253
Saioa Gómez-Zorita, Maitane González-Arceo, Jenifer Trepiana, Leixuri Aguirre, Ana B Crujeiras, Esperanza Irles, Nerea Segues, Luis Bujanda, María Puy Portillo. Comparative Effects of Pterostilbene and Its Parent Compound Resveratrol on Oxidative Stress and Inflammation in Steatohepatitis Induced by High-Fat High-Fructose FeedingAntioxidants 2020; 9(11): 1042 doi: 10.3390/antiox9111042
254
Waleska Dornas, Vincent Lagente. Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitisPharmacological Research 2019; 141: 418 doi: 10.1016/j.phrs.2019.01.026
255
Valerio Nobili, Antonella Mosca, Tommaso Alterio, Sabrina Cardile, Lorenza Putignani. Probiotics and Child Gastrointestinal HealthAdvances in Experimental Medicine and Biology 2018; 1125: 85 doi: 10.1007/5584_2018_318
256
Francesca Ubaldi, Claudia Frangella, Veronica Volpini, Paola Fortugno, Federica Valeriani, Vincenzo Romano Spica. Systematic Review and Meta-Analysis of Dietary Interventions and Microbiome in PhenylketonuriaInternational Journal of Molecular Sciences 2023; 24(24): 17428 doi: 10.3390/ijms242417428
257
Qiang Zheng, Hang Zhao, Dong Jia, Xu Han, Zhenning Liu, Min Zhao, Fumio Tsuji. Overexpression of TOLLIP Protects against Acute Kidney Injury after Paraquat Intoxication through Inhibiting NLRP3 Inflammasome Activation Modulated by Toll-Like Receptor 2/4 SignalingMediators of Inflammation 2021; 2021: 1 doi: 10.1155/2021/5571272
258
Firas Alhasson, Suvarthi Das, Ratanesh Seth, Diptadip Dattaroy, Varun Chandrashekaran, Caitlin N. Ryan, Luisa S. Chan, Traci Testerman, James Burch, Lorne J. Hofseth, Ronnie Horner, Mitzi Nagarkatti, Prakash Nagarkatti, Stephen M. Lasley, Saurabh Chatterjee, Partha Mukhopadhyay. Altered gut microbiome in a mouse model of Gulf War Illness causes neuroinflammation and intestinal injury via leaky gut and TLR4 activationPLOS ONE 2017; 12(3): e0172914 doi: 10.1371/journal.pone.0172914
259
Yizhe Cui, Qiuju Wang, Renxu Chang, Xiaocui Zhou, Chuang Xu. Intestinal Barrier Function–Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut MicrobiotaJournal of Agricultural and Food Chemistry 2019; 67(10): 2754 doi: 10.1021/acs.jafc.9b00080
260
Wenwen Zhao, Meng Xiao, Jie Yang, Li Zhang, Yinying Ba, Rongrong Xu, Zongyang Liu, Haiyan Zou, Ping Yu, Xia Wu, Xiaoqing Chen. The combination of Ilexhainanoside D and ilexsaponin A1 reduces liver inflammation and improves intestinal barrier function in mice with high-fat diet-induced non-alcoholic fatty liver diseasePhytomedicine 2019; 63: 153039 doi: 10.1016/j.phymed.2019.153039
261
Li‑Ping Han, Bei Sun, Chun‑Jun Li, Yun Xie, Li‑Ming Chen. Effect of celastrol on toll‑like receptor 4‑mediated inflammatory response in free fatty acid‑induced HepG2 cellsInternational Journal of Molecular Medicine 2018;  doi: 10.3892/ijmm.2018.3775
262
Sarit Anavi-Cohen, Gil Zandani, Nina Tsybina-Shimshilashvili, Ran Hovav, Noa Sela, Abraham Nyska, Zecharia Madar. Metabolic and Microbiome Alterations Following the Enrichment of a High-Fat Diet With High Oleic Acid Peanuts Versus the Traditional Peanuts Cultivar in MiceFrontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.823756
263
Sandra Martín-Peláez, Montse Fito, Olga Castaner. Mediterranean Diet Effects on Type 2 Diabetes Prevention, Disease Progression, and Related Mechanisms. A ReviewNutrients 2020; 12(8): 2236 doi: 10.3390/nu12082236
264
Dipro Bose, Punnag Saha, Ayan Mondal, Brian Fanelli, Ratanesh K. Seth, Patricia Janulewicz, Kimberly Sullivan, Stephen Lasley, Ronnie Horner, Rita R. Colwell, Ashok K Shetty, Nancy Klimas, Saurabh Chatterjee. Obesity Worsens Gulf War Illness Symptom Persistence Pathology by Linking Altered Gut Microbiome Species to Long-Term Gastrointestinal, Hepatic, and Neuronal Inflammation in a Mouse ModelNutrients 2020; 12(9): 2764 doi: 10.3390/nu12092764
265
Stanislav Kotlyarov. Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2023; 29(4): 597-615 doi: 10.3748/wjg.v29.i4.597
266
Cassandra Francella, Jane A. Foster. Burger's Medicinal Chemistry and Drug Discovery2021; : 1 doi: 10.1002/0471266949.bmc297